4.6 Article

Transient reactivity of vanadyl pyrophosphate, the catalyst for n-butane oxidation to maleic anhydride, in response to in-situ treatments

Journal

APPLIED CATALYSIS A-GENERAL
Volume 376, Issue 1-2, Pages 66-75

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.apcata.2009.10.037

Keywords

Vanadyl pyrophosphate; Maleic anhydride; n-Butane oxidation; Transient reactivity; In-situ Raman spectroscopy

Funding

  1. EU

Ask authors/readers for more resources

Two vanadyl pyrophosphate catalysts of n-butane oxidation to maleic anhydride differing slightly by their P/V atomic ratio (P/V = 1.00 or approximate to 1.05) were first equilibrated for 100 h at 400 degrees C to reach the steady-state. Then, their transient reactivity was studied during oxidizing or hydrolyzing in-situ treatments aimed at forcing changes in the characteristics of the active surface. The catalytic properties were monitored after the treatment to check if the latter has caused relevant changes of the active layer features with respect to those of the equilibrated samples. Treatments were carried out at 380 degrees C, a temperature at which the two catalysts exhibit rather different steady-state reactivity behaviour, and at 440 degrees C, where the two catalysts behave similarly. Accordingly, the transient catalytic behaviour of the two catalysts differed at 380 degrees C whereas at 440 degrees C only minor changes were observed. The comparison between transient reactivity tests. Raman spectra recorded in-situ and X-ray photoelectron spectra allowed to gain insights into how the P/V ratio affects the nature of the catalytically active layer and how the latter is modified after in-situ treatments. The major reversible variations of catalytic performance were observed after hydration and dehydration treatments. They are related to the distribution of vanadium phosphates (delta-VOPO4 or alpha(1)-VOPO4) and/or [VOy + (PO4)(n)] or VOPO4 center dot 2H(2)O on the catalyst surface. The nature of the formed compound depends on P/V ratio when an intermediate temperature, i.e., 380 degrees C, is used to carry out the treatments. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available